The SSc microangiopathy involves dramatic dysfunction in vascular regulatory mechanisms that presents initially with neural abnormalities, increased release of endothelin-1, and reduced release of nitric oxide and prostacyclin, and progresses to structural derangement of the involved vessels [3,30]. The gene discussed is EDN1; the disease is systemic sclerosis.